Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Retrospective Meet & Match Pharmaceutical Process Technology - 07/04/2016 DSC_0031.jpg

    Speed dating for Pharmaceutical Process Technology – a business flirt at Bosch

    The speed dating format is no longer just a popular and simple dating method for lonely hearts, but has also become a rewarding way for establishing new business contacts and connections quickly and efficiently. BIOPRO Baden-Württemberg chose speed networking, as speed dating is called in the corporate world, for its recent Meet & Match event on pharmaceutical process technology, which took place on 15th March 2016 with the support of Bosch…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/speed-dating-for-pharmaceutical-process-technology-a-business-flirt-at-bosch
  • Medical technology - 14/03/2016 Experimenteller_Interventionsraum_mit_mobilen_Rontgengerat_Monitoren_und_OP-Tisch_an_dem_der_Interventionsassistent_herangefahren_werden_kann.jpg

    The operating room of the future: minimally invasive and future-oriented intervention techniques

    Being able to diagnose and treat tumour patients in just a few hours is just one of the many promising goals of the Fraunhofer Project Group for Automation in Medicine and Biotechnology (PAMB). The overall goal of the Intervention and Therapy research group is to take innovative technologies for diagnostic and therapeutic interventions from laboratory development to prototype production for use in clinical trials.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-operating-room-of-the-future-minimally-invasive-and-future-oriented-intervention-techniques
  • Article - 02/02/2016 Innovation.jpg

    EU consortium to speed up innovations in the healthcare sector

    EIT Health is a large-scale European project launched in December 2014 that aims to help people in Europe to live a healthier life and stay active as they grow older. The consortium brings together 140 leading companies and institutions from 14 European countries and has a total budget of two billion euros. It is one of the largest networks worldwide in the healthcare sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/eu-consortium-to-speed-up-innovations-in-the-healthcare-sector
  • Press release - 16/11/2015 BP-Branchenreport-2015-R-Web.jpg

    The Baden-Württemberg healthcare industry – a strong economic power

    (Stuttgart – 16th November 2015) BIOPRO Baden-Württemberg has just published its latest analysis of the Baden-Württemberg healthcare industry including comprehensive facts and figures. Baden-Württemberg continues to be one of the top locations for medical technology, pharma and biotechnology in Germany.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-baden-wuerttemberg-healthcare-industry-a-strong-economic-power
  • Article - 04/11/2015 NMI-Mikrofluidikchip.jpg

    DNA capture molecules wanted for cells

    Artificial blood vessels made of special polymers are no longer a pipedream. However, one problem that needs to be solved is that the artificial vessels have to be compatible with tissue. One solution could be to dupe the body into thinking that the artificial vessels are real by coating their inside walls with the patient’s own cells. Researchers from Reutlingen have developed a microfluidic chip that identifies molecules that can capture the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/dna-capture-molecules-wanted-for-cells
  • Press release - 03/11/2015 07777_de.jpg

    CureVac raises $110 Million in a private placement

    CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline. CureVac also announces the change of its corporate legal form to a joint stock company, Aktiengesellschaft (AG).

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-raises-110-million-in-a-private-placement
  • Telemedizin - 19/10/2015 User interface of a social medical application platform.

    SMARTY – a new way to treat and care for chronically ill children

    Chronic and complex diseases in children are often a heavy burden on their families. Parents naturally want their children to have the latest treatment, and children are usually treated by several specialists. This makes it rather difficult, or, at the very least, involves considerable effort to keep everyone up to date. Dr. Joachim Riethmüller from the University Children’s Hospital in Tübingen and his team of doctors are using telemedicine in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/smarty-a-new-way-to-treat-and-care-for-chronically-ill-children
  • Press release - 30/09/2015 23349_de.jpg

    Vetter Embarks on a 300 Million Euro Investment Strategy for Further Development To its Manufacturing Sites and to make available Additional Manufacturing Capacities

    Vetter has announced that in keeping with its commitment to providing customers with the manufacture of high quality drug products, the company will invest approximately 300 million euros to expand and upgrade its manufacturing facilities over an estimated five-year period. As a leading contract development and manufacturing organization, Vetter is continuously developing its manufacturing sites and techniques to prepare them for future needs and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-embarks-on-a-300-million-euro-investment-strategy
  • Article - 21/09/2015 Schematic of a test strip (horizontal) illustrating the principle of competitive immunoassays that play a key role in detecting small analytes with a single epitope. The flow direction in the capillary is from left to right. Analytes (small molecules) are added to the test strip (on the left), which will initially come into contact with nanoparticle-antibody conjugates, then on a test and control area.

    Hans-Peter Deigner: "Optimisation of lateral flow assays using nanoparticles."

    Nanoparticles are already used in many materials and areas, ranging from textiles to scientific and medical research. The global scientific community is keenly interested in nanoparticle research and Prof. Dr. Hans-Peter Deigner, professor in the Faculty of Medical and Life Sciences at Furtwangen University of Applied Sciences (HFU) is no exception. Deigner works on optimising nanoparticles for application in lateral flow assays. As well as…

    https://www.gesundheitsindustrie-bw.de/en/article/news/hans-peter-deigner-optimisation-of-lateral-flow-assays-using-nanoparticles
  • Press release - 11/09/2015

    Venneos raises seed round of 1 million euros

    Venneos GmbH is based in Stuttgart and develops a novel imaging system for the analysis of biological cells. A consortium of business angels and family offices, along with the High-Tech Gründerfonds and Max Planck Society invest in the company to develop a market-ready product and prepare the market entry of the first product generation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/venneos-raises-seed-round-of-1-million-euros
  • Article - 31/08/2015 roth.jpg

    Company foundation in Baden-Württemberg: Günter Roth and the biomolecule copier

    Dr. Günter Roth is head of the “Microarray Copying“ research group at the Center for Biological Systems Analysis (ZBSA) at the University of Freiburg. Roth, who studied physics and biochemistry, has developed a biomolecule copier that he plans to use to establish his own company. The company will be called BioCopy, and the planned product lines, AptaSWIFT and immune2day, have already won numerous prizes for Roth and his team. In an interview with…

    https://www.gesundheitsindustrie-bw.de/en/article/news/company-foundation-in-baden-wuerttemberg-guenter-roth-and-the-biomolecule-copier
  • Article - 27/07/2015 vanpoelgeest_teaser.jpg

    Fraunhofer PAMB accelerates the development of medical devices

    Dr. Auguste van Poelgeest is head of the “Control Systems for Medical Engineering” research group that is part of the Project Group for Automation in Medicine and Biotechnology (PAMB). The project group is based at the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. In an interview with Dr. Ariane Pott from BIOPRO Baden-Württemberg, van Poelgeest explains the role of automation in the field of medicine and how…

    https://www.gesundheitsindustrie-bw.de/en/article/news/fraunhofer-pamb-accelerates-the-development-of-medical-devices
  • Overview

    Events for the healthcare industry

    https://www.gesundheitsindustrie-bw.de/en/event
  • Overview

    Latest news

    Here you can find the latest articles about the Baden-Württemberg healthcare industry.

    https://www.gesundheitsindustrie-bw.de/en/article/news
  • Article - 15/06/2015 Schematic presentation of molecular diagnostic procedures and bioinformatic analyses used for cancer patients.

    Centre for Personalised Medicine in Tübingen - developing tailor-made treatments for patients

    Since January 2015, Tübingen has been home to a Centre for Personalised Medicine (ZPM). Twenty-three institutes and hospitals have joined forces to improve diagnosis of disease and develop individualised treatments for patients with a variety of diseases. In parallel, the centre also develops new diagnostic strategies. This means, for example, that data derived from the analysis of the entire genetic material of cells, proteins and metabolic…

    https://www.gesundheitsindustrie-bw.de/en/article/news/centre-for-personalised-medicine-in-tuebingen-developing-tailor-made-treatments-for-patients
  • Overview

    BIOPRO services and offers

    As a 100% affiliate of the Baden-Württemberg government, BIOPRO Baden-Württemberg GmbH provides targeted support to the pharmaceutical industry and the biotechnology and medical technology sectors as well as supporting the development of a bioeconomy.

    https://www.gesundheitsindustrie-bw.de/en/biopro/services
  • Overview

    Information channels

    The following information channels will help you stay up-to-date on the healthcare industry.

    https://www.gesundheitsindustrie-bw.de/en/biopro/info
  • Overview

    Contacts

    BIOPRO Baden-Württemberg GmbH is the central point of contact for the healthcare industry in Baden-Württemberg. If you have questions relating to the “Baden-Württemberg Healthcare Industry” portal, please feel free to contact BIOPRO’s editorial office. Questions about the healthcare industry in general or BIOPRO’s healthcare industry services should be addressed to BIOPRO’s Team Healthcare.

    https://www.gesundheitsindustrie-bw.de/en/biopro/contact
  • Overview

    Basic research

    The latest articles, press releases and dossiers on basic research in Baden-Württemberg

    https://www.gesundheitsindustrie-bw.de/en/article/research
  • Overview

    Selected publications

    Here you can download selected publications on the Baden-Württemberg healthcare industry.

    https://www.gesundheitsindustrie-bw.de/en/article/publication
  • Overview

    Diagnostics

    The latest articles, press releases and dossiers on diagnostics in Baden-Württemberg

    https://www.gesundheitsindustrie-bw.de/en/article/diagnostics
  • Overview

    Red biotechnology

    The latest articles, press releases and dossiers on red biotechnology in Baden-Württemberg

    https://www.gesundheitsindustrie-bw.de/en/article/biotech
  • Overview

    Medical technology

    The latest articles, press releases and dossiers on medical technology in Baden-Württemberg

    https://www.gesundheitsindustrie-bw.de/en/article/medtech
  • Overview

    Clusters and networks

    The Baden-Württemberg research and business landscape is characterised by a large number of clusters, networks and bioregions.

    https://www.gesundheitsindustrie-bw.de/en/location/networks

Page 4 / 21

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 21
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search